Home ›
Trademark Categories ›
Pharmaceuticals ›
2005 ›
HE ›
HEMOMER
Trademark search for:
HEMOMER
No active United States Patent and Trademark Office (USPTO) registrations found, based on publicly available USPTO trademark records.
Trademark records may change over time.
For the most up-to-date trademark status, domain availability,
and social handle checks, run a live search.
Check latest trademark, domains & social handles
Live search · Most up-to-date results
USPTO Filing History
Key events recorded for this trademark application
2009-11-19 — Application filed
2009-12-24 — Sn assigned for sect 66a appl from ib
2009-12-28 — Limitation of goods/services from ib entered
2009-12-29 — Application filed
2010-01-02 — Application filed
2010-02-25 — Assigned to examiner
2010-03-04 — Final disposition recorded
2010-03-05 — Office action issued
2010-03-05 — Office action issued
2010-03-05 — Office action issued
2010-03-26 — Office action issued
2010-09-02 — Teas/email correspondence entered
2010-09-02 — Office action issued
2010-09-02 — Correspondence received in law office
2010-09-11 — Approved for pub - principal register
2010-09-13 — Correction transaction received from ib
2010-09-20 — Assigned to lie
2010-09-20 — Correction from ib entered - no review required
2010-09-20 — Law office publication review completed
2010-10-26 — Published for opposition
2010-10-26 — Official gazette publication confirmation e-mailed
2011-01-11 — Registered-principal register
2011-04-11 — Final disposition recorded
2011-05-13 — Final disposition recorded
2011-05-13 — Final disposition recorded
2013-02-18 — Final disposition recorded
2016-08-11 — New representative at ib received
2017-08-18 — Cancelled section 71
2018-04-18 — Total invalidation of reg ext protection created
2018-04-23 — Total invalidation of reg ext protection sent to ib
2018-04-23 — Invalidation processed
2018-05-19 — Total invalidation processed by the ib
2019-11-19 — Final status recorded
2020-12-19 — Death of international registration
2020-12-19 — Notification of effect of cancellation of intl reg mailed
Owner Information
AplaGen GmbH
DE
AplaGen GmbH
DE
AplaGen GmbH
DE
Correspondent
Lawrence E. Abelman Abelman Frayne & Schwab 666 Third Avenue 10th Floor New York, NY 10017
Filing Details
Filing Date:
2009-11-19
Status Date:
2019-11-19
Disclaimer: This page is informational only and does not constitute legal advice.
Trademark availability depends on jurisdiction, usage, and legal interpretation.